Steven holds a Ph.D in microbiology and biofilms, a HND and B.Sc in Applied Biological Sciences, Postgraduate Certificate in Education, diploma in Business Administration, an M.Sc in Public Health and an M.Sc in Medical and Molecular Microbiology. Early in his career Steven held R&D positions at Phenomenex, The British Textile Technology Group, six years as a senior university lecturer in medical microbiology and principal consultant for numerous government and industrial bodies. Following this he held the position of Chief Scientific Officer and Global Director of Research and Development at Aseptica Inc. and in 2002 was also awarded prestigious Centres for Disease Control (CDC) senior clinical microbiology fellowship to develop novel anti-biofilm technologies in Atlanta, USA. More recently Steven has held senior R&D positions at Bristol Myers Squibb and ConvaTec, Advanced Medical Solutions Plc and an honorary Professorship in Medical Microbiology at West Virginia University. In 2011 he joined Scapa Healthcare as Vice President of Global Healthcare R&D. He also holds the position of honorary Professor in the Surface Science Research Centre at The University of Liverpool. In addition, Steven is an editor of the Journal of Medical Microbiology and sits on the editorial boards of a number of other journals including Chronic Wound Care Management and Research, The Open Veterinary Science Journal, BMC Microbiology, Anticorrosion Methods and Materials and the International Journal of Burns and Trauma. He has written over 350 scientific publications and conference abstracts on biofilms, antimicrobials, and infection control, authored and edited seven biofilm and microbiology textbooks and provided over 120 presentations world-wide. He is a global key opinion leader on biofilms, antimicrobials, wound infections and infection control.
Biofilms; Antimicrobials; Infection Control; Hospital Acquired Infections; Medical Device Related Infections; Wound and Skin Infections; Probiotics; Waterborne Diseases.